-
1.
公开(公告)号:US20190151299A1
公开(公告)日:2019-05-23
申请号:US16308859
申请日:2017-06-08
发明人: Fei SUN , Lifang WU , Charles Z. DING , Guoping HU , Jian LI , Shuhui CHEN , Jianyu LU
IPC分类号: A61K31/4439 , A61P35/00
摘要: A benzotriazole-derived α and β-unsaturated amide compound used as TGF-βR1 inhibitor or a pharmaceutically acceptable salt thereof, the structure of the compound being as shown in formula (I).
-
公开(公告)号:US20210079021A1
公开(公告)日:2021-03-18
申请号:US16771977
申请日:2018-12-13
发明人: Lifang WU , Huijun HE , Jianyu LU , Charles Z. DING , Lihong HU , Weidong LI , Shenyi SHI , Jian LI , Shuhui CHEN
IPC分类号: C07D519/00
摘要: Disclosed in the present invention are a crystal form and salt form of a TGF-βR1 inhibitor and a preparation method therefor, and further disclosed is an application of the crystal form and the salt form in preparation of medicines for treating cancers.
-
公开(公告)号:US20240109861A1
公开(公告)日:2024-04-04
申请号:US18270317
申请日:2021-12-30
发明人: Kevin X CHEN , Li ZHANG , Houze GUI , Haoyu ZHANG , Huiyu ZHANG , Guoping HU , Jian LI , Shuhui CHEN
IPC分类号: C07D401/06 , A61P13/12 , C07D405/14
CPC分类号: C07D401/06 , A61P13/12 , C07D405/14
摘要: A series of piperidine-substituted benzoic acid compounds and the use thereof, and specifically disclosed is a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20230365558A1
公开(公告)日:2023-11-16
申请号:US18245551
申请日:2021-09-18
发明人: Kevin X CHEN , Zuhao GUO , Yanxin YU , Boyu HU , Jingjing WANG , Zhaoguo CHEN , Cheng XIE , Jian XIONG , Yongbo FANG , Yingtao LIU , Jian LI , Shuhui CHEN
IPC分类号: C07D471/04 , C07D413/12 , C07D498/04 , C07D498/10 , C07D401/12 , A61P35/00
CPC分类号: C07D471/04 , C07D413/12 , C07D498/04 , C07D498/10 , C07D401/12 , A61P35/00 , C07B2200/13
摘要: A series of tetrahydroisoquinoline derivatives and the crystal forms thereof. Specifically disclosed are a compound as represented by formula (VII), a crystal form thereof, and a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20230357272A1
公开(公告)日:2023-11-09
申请号:US17906762
申请日:2021-04-06
发明人: Shuhui CHEN , Kevin X CHEN , Kai ZHOU , Wen JIANG , Guoping HU , Jian LI
IPC分类号: C07D498/22 , C07D471/22 , A61P35/00
CPC分类号: C07D498/22 , C07D471/22 , A61P35/00
摘要: Disclosed is a class of octahydropyrazinodiazanaphthyridine dione compounds, and specifically disclosed are a compound as shown in formula (III) and a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20230128137A1
公开(公告)日:2023-04-27
申请号:US17910536
申请日:2021-03-08
发明人: Hongjian WANG , Wenyuan QIAN , Ming ZHANG , Jian LI , Shuhui CHEN
IPC分类号: C07D471/04 , A61P35/00
摘要: A benzo five-membered cyclic compound represented by formula (I) or a pharmaceutically acceptable salt thereof has a significant effect in inhibiting the activity of anti-apoptotic Bcl-2 protein.
-
公开(公告)号:US20230094146A1
公开(公告)日:2023-03-30
申请号:US17790985
申请日:2021-01-07
发明人: Zhifei FU , Miaorong LUO , Yang ZHANG , Jian LI , Shuhui CHEN
IPC分类号: C07D495/04
摘要: Disclosed is a deuterated thienopyridine compound. Specifically disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20220112217A1
公开(公告)日:2022-04-14
申请号:US17270372
申请日:2019-08-21
发明人: Chengde WU , Jingjie HUANG , Tao YU , Jie LI , Zhen GONG , Jian LI , Shuhui CHEN
IPC分类号: C07D519/00 , A61P35/00
摘要: A series of pyrazolopyrimidine derivatives can be used in preparing a medicament for treating a disease related to PI3K. For example, a compound of formula (I), a tautomer thereof or a pharmaceutically acceptable composition thereof are effective in treating a disease related to P13K.
-
公开(公告)号:US20210380599A1
公开(公告)日:2021-12-09
申请号:US17280538
申请日:2019-09-27
发明人: Wenyuan QIAN , Chundao YANG , Guoqiang DAI , Jian LI , Shuhui CHEN
IPC分类号: C07D491/20 , A61K31/7048 , A61P35/00 , C07D471/04 , C07D471/20
摘要: Disclosed are a series of quinolino-pyrrolidin-2-one compounds, and application thereof in preparation of drugs for ATM inhibitor-related diseases. The present disclosure specifically relates to a derivative compound represented by formula (I), tautomers thereof or pharmaceutically acceptable compositions thereof.
-
公开(公告)号:US20210371411A1
公开(公告)日:2021-12-02
申请号:US16962951
申请日:2019-01-18
发明人: Yaxian CAI , Zhaobing XU , Hailong YANG , Shiqi HAN , Guoping HU , Lihong HU , Charles Z. DING , Jian LI , Shuhui CHEN
IPC分类号: C07D471/04 , C07D519/00 , A61P35/00
摘要: Provided are a class of KRAS G12C mutein inhibitors, which relate in particular to a compound represented by formula (I), an isomer thereof, and a pharmaceutically acceptable salt thereof.
-
-
-
-
-
-
-
-
-